Current status: 1070 hESC lines, 6872 hiPSC lines, and 175 clinical studies, and 2400 certificates
Monthly statistic from Mar 1, 2025
Posted on March 1, 2025
total lines | 7942 |
hESC lines | 1070 |
hiPSC lines | 6872 |
derivation countries | 50 |
projects | 315 |
providers | 964 |
clinical studies | 175 |
subclones | 3410 |
certificates | 2400 |
cell line certificates | 2253 |
project certificates | 147 |